Maravai LifeSciences Holdings, holding history
As of Nov. 6, 2026 (UTC)
| Sept. 30, 2025 | 136,409 | $391,494 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 31, 2025 |
| Dec. 31, 2025 | 1,585,316 | $5,152,277 | 0.29% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 1,716,193 | $4,856,826 | 0.32% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2026 |
| June 30, 2026 | 1,716,193 | $10,709,044 | 0.63% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 31, 2026 |
| Sept. 30, 2026 | 1,716,193 | $13,146,038 | 0.77% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 2, 2026 |
5 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.